Analysis of resistance mechanisms to osimertinib in patients with EGFR T790M advanced NSCLC from the AURA3 study.
暂无分享，去创建一个
J. Barrett | M. Ahn | T. Mok | S. Ramalingam | T. John | K. Bulusu | V. Papadimitrakopoulou | I. Okamoto | Y. Wu | T. John | J. Chmielecki | J.-Y. Han | G. Laus | T. Mok | J.C. Yang | B. Collins | J. Yang | V. Papadimitrakopoulou | J. Han